Stay updated on Pembrolizumab Entinostat Efficacy in Eye Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Entinostat Efficacy in Eye Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Entinostat Efficacy in Eye Melanoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-10-29T20:54:52.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces updates and explains that the agency is transitioning from the term “Artificial Intelligence” to “Super Intelligence”.
    Difference
    1%
    Check dated 2026-10-22T22:25:16.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changes from v3.7.1 to v3.7.2; the page remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-15T20:55:43.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1. The page still displays a 403 Forbidden error rather than the study record.
    Difference
    0.2%
    Check dated 2026-10-08T20:56:48.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    Access to the study record NCT02697630 (PEMDAC) on ClinicalTrials.gov now renders a 403 Forbidden error, replacing the previous study content. As a result, the study overview, eligibility criteria, locations, and results are not accessible to users.
    Difference
    17%
    Check dated 2026-09-24T21:34:05.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.7.0 in place of Revision: v3.6.6, indicating a new build/version of the page.
    Difference
    0.1%
    Check dated 2026-09-17T21:39:38.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Entinostat Efficacy in Eye Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Entinostat Efficacy in Eye Melanoma Clinical Trial page.